Literature DB >> 16018245

Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

C Kailasam1, V Akande, U D Gordon.   

Abstract

We report the safe use of levonorgestrel hormone releasing intra uterine system (Mirena) as a contraceptive in egg donors during a treatment cycle. In the first case report, a 29-year-old egg donor using the Mirena coil for contraception and two egg recipients, aged 41 years and 32 years respectively underwent standard IVF treatment, oocyte retrieval in the egg donor and in vitro fertilization followed by embryo transfer in the recipient. The outcome of IVF cycle using donor eggs was satisfactory with successful pregnancy in the egg recipient. The second case involved a 34-year-old egg donor using the Mirena coil and a 44-year-old recipient. Our findings suggest that egg donors can safely use the (Mirena) as a contraceptive device during treatment, without compromising follicular development and oocyte quality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018245      PMCID: PMC3455176          DOI: 10.1007/s10815-005-4889-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  14 in total

1.  Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.

Authors:  S G Silverberg; M Haukkamaa; H Arko; C G Nilsson; T Luukkainen
Journal:  Int J Gynecol Pathol       Date:  1986       Impact factor: 2.762

2.  Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.

Authors:  F Alvarez; V Brache; A Faundes; A S Tejada; F Thevenin
Journal:  Contraception       Date:  1996-11       Impact factor: 3.375

3.  Sustained intrauterine release of levonorgestrel over five years.

Authors:  C G Nilsson; P L Lahteenmaki; T Luukkainen; D N Robertson
Journal:  Fertil Steril       Date:  1986-06       Impact factor: 7.329

Review 4.  Levonorgestrel-releasing intrauterine device.

Authors:  T Luukkainen; P Lähteenmäki; J Toivonen
Journal:  Ann Med       Date:  1990-04       Impact factor: 4.709

Review 5.  Progestin-releasing intrauterine systems.

Authors:  T Luukkainen; P Pakarinen; J Toivonen
Journal:  Semin Reprod Med       Date:  2001-12       Impact factor: 1.303

Review 6.  Mechanisms that explain the contraceptive action of progestin implants for women.

Authors:  Horacio B Croxatto
Journal:  Contraception       Date:  2002-01       Impact factor: 3.375

7.  Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.

Authors:  C Kailasam; S D Keay; P Wilson; W C L Ford; J M Jenkins
Journal:  Hum Reprod       Date:  2004-05-13       Impact factor: 6.918

Review 8.  Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.

Authors:  T Luukkainen; J Toivonen
Journal:  Contraception       Date:  1995-11       Impact factor: 3.375

9.  Sex hormone binding globulin: the carrier protein for d-norgestrel.

Authors:  A Victor; E Weiner; E D Johansson
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

10.  Effects of levonorgestrel on capacity of mouse oocytes for fertilization and development.

Authors:  B Shirley; J C Bundren
Journal:  Contraception       Date:  1995-03       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.